Deterioration in the Creditworthiness of Medical Equipment Customers
First written in FY2016. 25 of 26 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2026: 23 of 72 companies on the "Worse" side.
- FY2025RestatedAnnual report
「The Group monitors customers' creditworthiness and pays attention to the management of trade receivables, including requesting collateral where necessary.」
The risk of deterioration in customers' creditworthiness and the response through monitoring creditworthiness, obtaining collateral and managing trade receivables continue to be described. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2022RestatedAnnual report
「If customers' creditworthiness deteriorates significantly, the Group's performance may be affected. …The Group monitors customers' creditworthiness and pays attention to the management of trade receivables, including requesting collateral where necessary.」
The risk of deterioration in customers' creditworthiness and the response through monitoring creditworthiness, obtaining collateral and managing trade receivables have been reconfirmed. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2021RestatedAnnual report
「The Group monitors customers' creditworthiness and pays attention to the management of trade receivables, including requesting collateral where necessary.」
The risk of deterioration in customers' creditworthiness and the response through monitoring creditworthiness, obtaining collateral and managing trade receivables continue to be described. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2018RestatedAnnual report
「As a result of lower selling prices in the medical device business, intensifying competition and other factors, some of these customers may experience increasingly difficult business conditions. The Group pays attention to the management of trade receivables, but if customers' creditworthiness deteriorates significantly, the Group's performance may be affected.」
The possibility of deterioration in customers' business conditions and creditworthiness, and the continued management of trade receivables, are described. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no new developments or material changes. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2017-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risk of deterioration in the creditworthiness of medical device customers has been reconfirmed through a comprehensive statement that there have been no material changes. - FY2016First statedAnnual report
「As a result of lower selling prices in the medical device business, intensifying competition and other factors, some of these customers may experience increasingly difficult business conditions.」
The credit risk arising from deterioration in customers' business conditions is recognized, and attention is being paid to the management of trade receivables.